Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Atara Biotherapeutics

United States — Food and Drug Administration & Atara Biotherapeutics

4 shared events · Importance 5 · Last updated May 27, 2026

Importance
5
Shared Events
4
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (4)
0
Business
Atara Biotherapeutics Class Action Lawsuit
Atara Biotherapeutics: Atara Biotherapeutics is the defendant in a class action lawsuit alleging false and misleading statements regarding its business, operations, and prospects, specifically concerning the regulatory approval of its lead product candidate, tabelecleucel. Its stock price experienced significant declines following FDA decisions.
May 01, 2026 · 6 articles
0
Business
Atara Biotherapeutics Securities Class Action
Apr 01, 2026 · 58 articles
0
Business
Atara Biotherapeutics Class Action Lawsuit
Apr 02, 2026 · 20 articles
0
Tech
Calidi Biotherapeutics RedTail Platform Data
Apr 01, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Atara Biotherapeutics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.